Eve Burstein
Stock Analyst at Bernstein
(2.63)
# 1,999
Out of 5,161 analysts
24
Total ratings
46.15%
Success rate
24.29%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $145 → $125 | $115.42 | +8.30% | 5 | Apr 16, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $196.61 | +1.72% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $89.63 | +61.78% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $297.54 | +20.99% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $103.40 | -12.96% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $88.03 | -60.24% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $495.72 | +25.07% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.35 | +85.19% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $8.29 | +165.38% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $121.50 | -8.64% | 1 | Sep 28, 2023 |
Agilent Technologies
Apr 16, 2025
Maintains: Market Perform
Price Target: $145 → $125
Current: $115.42
Upside: +8.30%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $196.61
Upside: +1.72%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $89.63
Upside: +61.78%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $297.54
Upside: +20.99%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $103.40
Upside: -12.96%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $88.03
Upside: -60.24%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $495.72
Upside: +25.07%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.35
Upside: +85.19%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $8.29
Upside: +165.38%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $121.50
Upside: -8.64%